Precore stop mutant in HBeAg-positive patients with chronic hepatitis B: Clinical characteristics and correlation with the course of HBeAg-to-anti-HBe seroconversion

Journal of Clinical Microbiology

Volumn 40, Issue 1, 2002, Pages 16-21

  Chu, C M ^a   Yeh, C T ^a   Lee, C S ^a   Sheen, I S ^a   Liaw, Y F ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B(E) ANTIBODY; HEPATITIS B(E) ANTIGEN; VIRUS DNA;

ADULT; ARTICLE; CHRONIC HEPATITIS; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION FUNCTION; DNA DETERMINATION; FEMALE; HEPATITIS B; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SEROCONVERSION; VIREMIA;

ADOLESCENT; ADULT; CODON; DISEASE PROGRESSION; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B E ANTIGENS; HEPATITIS B VIRUS; HEPATITIS, CHRONIC; HUMANS; MALE; MIDDLE AGED; MUTATION;

DNA VIRUSES; HEPATITIS B VIRUS;

EID: 0036136512     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.40.1.16-21.2002     Document Type: Article

References (39)

1. Chronic active hepatitis with hepatitis B virus DNA and antibody against e antigen in the serum
2. Chronic hepatitis in HBsAg carriers with serum HBV-DNA and anti-HBe
3. Which patients with chronic hepatitis B virus infection will respond to alpha-interferon therapy? A statistical analysis of predictive factors
4. Identification of HBV variants which cannot produce precore-derived HBeAg and may be responsible for severe hepatitis
5. Hepatitis B virus unable to secrete e antigen and response to interferon in chronic hepatitis B
6. Wild-type and e antigen-minus hepatitis B viruses and course of chronic hepatitis
7. Mutation preventing formation of e antigen in patients with chronic HBV infection
8. Expression of the precore region of an avian hepatitis B virus is not required for viral replication
9. The precore gene of the woodchuck hepatitis B virus genome is not essential for viral replication in the natural host
10. Natural history of chronic hepatitis B virus infection in Taiwan: Studies of hepatitis B virus DNA in serum
11. Precore mutant of hepatitis B virus prevails in acute and chronic infections in an area in which hepatitis B is endemic
12. Spontaneous reactivation of chronic hepatitis B virus infection
13. Hepatitis B virus precore/core variation and interferon therapy
14. High genomic variability in the pre-C region of hepatitis B virus in anti-HBe, HBV DNA-positive chronic hepatitis
15. Analysis of nuclear HBcAg, viral replication and hepatitis B virus DNA in liver and serum of HBeAg vs. anti-HBe positive carriers of hepatitis B virus
16. Hepatitis B e antigen negative chronic hepatitis B: From clinical recognization to pathogenesis and treatment
17. Changes in the prevalence of HBeAg-negative mutant hepatitis B virus during the course of chronic hepatitis B
18. Seroconversion from hepatitis B e antigen to antibody in chronic type B hepatitis
19. Clinical and histological events preceding hepatitis B e antigen seroconversion in chronic type B hepatitis
20. Acute exacerbation in chronic type B hepatitis: Comparison between HBeAg and antibody-positive patients
21. Current therapeutic trends in therapy for chronic viral hepatitis
22. Detection of hepatitis B virus precore TAG mutant by an amplification-created restriction site method
23. Contribution of low level HBV replication to continuing inflammatory activity in patients with anti-HBe positive chronic hepatitis B virus infection
24. Spontaneous hepatitis B e antigen to antibody seroconversion and reversion in Chinese patients with chronic hepatitis B virus infection
25. Predictive value of precore hepatitis B virus mutations in spontaneous and interferon-induced hepatitis B e antigen clearance
26. Precore mutant hepatitis B virus infection and liver disease
27. Precore region mutation in hepatitis B virus genome in early stage of infection: A study in hepatitis B e antigen-positive young carriers
28. Hepatitis B viruses with precore region defects prevail in persistently infected hosts along with seroconversion to antibody against e antigen
29. Quantitative analysis of serum HBV pre-core mutant in HBV carriers
30. A randomized controlled trial of interferon alfa-2b alone and after prednisolone withdrawal for the treatment of chronic hepatitis B
31. Seroconversion from hepatitis B e antigen to anti-HBe in chronic hepatitis B infection
32. High prevalence and heterogeneity of HBV preC mutants in anti-HBe-positive carriers with chronic liver disease in Southern Italy
33. Epidemiological study on hepatitis B virus infection in Taiwan
34. Defects in the precore region of the HBV genome in patients with chronic hepatitis B after sustained seroconversion from HBeAg to anti-HBe induced spontaneously or with interferon therapy
35. The emergence of envelope and precore/core variants of hepatitis B virus: The potential role of antibody selection
36. Active hepatitis B virus replication in the presence of anti-HBe is associated with viral variants containing an inactive pre-C region
37. Hepatitis B virus precore mutants are identical in carriers from various ethnic origins and are associated with a range of liver disease severity
38. Absence of hepatitis B virus precore mutants in patients with chronic hepatitis B responding to interferon-alpha
39. Progression of the proportion of hepatitis B virus precore stop mutant following acute superinfection of hepatitis C